Suppr超能文献

注射吸毒人群的死亡率:丙型肝炎病毒队列的十年随访。

Mortality among people who inject drugs: Ten-year follow-up of the hepatitis C virus cohort.

机构信息

Kirby Institute; UNSW Sydney, Sydney, Australia.

National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.

出版信息

Drug Alcohol Rev. 2019 Mar;38(3):270-273. doi: 10.1111/dar.12884. Epub 2018 Dec 21.

Abstract

INTRODUCTION AND AIMS

Mortality studies of people who inject drugs (PWID) are mostly of older people and drug treatment cohorts. We estimate mortality rates, describe causes of death, and years of potential life lost in a community-recruited cohort of young PWID characterised by high incidence of hepatitis C virus (HCV) infection.

DESIGN AND METHODS

Participant identifiers of 215 PWID from the south-western Sydney sub-cohort of the HCV Cohort were linked to National Death Index records from 1999 to 2010 and crude mortality rates and standardised mortality ratios estimated. Australian life tables were used to calculate years of potential of life lost.

RESULTS

Fifteen participants died (7.0%) in 2095 person years (PY) of follow-up. Median age at death was 30.6 years (interquartile range 24.9-32.2). The crude mortality rate was 0.72 per 100PY (95% confidence interval 0.29-0.79) with a standardised mortality ratio of 11.09 (95% confidence interval 6.68-18.39). One-third of deaths were due to accidental drug overdose (5/15) and one-fifth were suicides (3/15). All deaths from defined causes (13/15) were potentially avoidable. Decedents lost on average 49.8 years of potential life.

DISCUSSION AND CONCLUSIONS

Mortality and potential life lost further highlight the impact of accidental overdose deaths and suicide among young PWID. Integration of overdose and suicide prevention into youth-orientated outreach, including innovation in online and mobile technology should be evaluated.

摘要

引言和目的

对注射吸毒者(PWID)的死亡率研究大多针对老年人和接受药物治疗的队列。我们评估了一个具有高丙型肝炎病毒(HCV)感染率的年轻 PWID 社区招募队列的死亡率、描述死因,并计算潜在寿命损失年数。

设计和方法

将来自 HCV 队列的西南悉尼子队列的 215 名 PWID 的参与者标识符与 1999 年至 2010 年的国家死亡指数记录进行链接,并估算了粗死亡率和标准化死亡率比。使用澳大利亚生命表计算潜在寿命损失年数。

结果

在 2095 人年(PY)的随访中,有 15 名参与者(7.0%)死亡。死亡时的中位年龄为 30.6 岁(四分位间距 24.9-32.2)。粗死亡率为 0.72/100PY(95%置信区间 0.29-0.79),标准化死亡率比为 11.09(95%置信区间 6.68-18.39)。三分之一的死亡是由于意外药物过量(15/15),五分之一是自杀(15/15)。所有有明确死因的死亡(13/15)都是可以避免的。死者平均损失 49.8 年的潜在寿命。

讨论和结论

死亡率和潜在寿命损失年数进一步强调了意外药物过量死亡和年轻 PWID 自杀的影响。应评估将药物过量和自杀预防纳入以青年为导向的外展工作中,包括在线和移动技术方面的创新。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验